FASTinov AST kits are CE-marked, approved for sale in the European Union under IVD Directive. They are not FDA-cleared and are not yet available for sale in the U.S. Availability in each country depends on local regulatory clearance.
LEARN MORE

Phenotypic Antimicrobial Susceptibility in 2 hours directly from blood cultures.

FASTinov AST delivers phenotypic Antimicrobial Susceptibility Testing within 2 hours, with superior precision for both gram negative and gram positive panels.

Now CE-Marked

The world’s fastest antibiogram

LEARN MORE

The FASTinov AST uses flow cytometry to detect lesions that happen in the first minutes of contact between bacteria and antibiotics.
Because it doesn’t depend on bacterial growth, the results are always obtained in less than 2 hours.

FASTEST phenotypic susceptibility test for both gram negative and gram positive bacteria

Impact

Antimicrobial Resistance (AMR) is a WHO top 10 global health threat. **

An estimated 1.27 million deaths were caused by baterian AMR in 2019.***

Rapid antimicrobial Susceptibility Testing is a key intervention to effectively manage critically infected patients and fight AMR. ****

By offering an AST report in 2h, instead of the 24-48h of current systems, FASTinov AST provides a new option to manage critical infection at any time of the day.

The impact of FASTinov AST report in 2h
** World Health Organization http://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

*** Murray, Christopher JL et al., Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, Lancet, 19 Jan 2022 DOI: https://doi.org/10.1016/S0140-6736(21)02724-0

**** van Belkum, Alex et al. “Innovative and rapid antimicrobial susceptibility testing systems.” Nature reviews. Microbiology vol. 18,5 (2020): 299-311. doi:10.1038/s41579-020-0327-x

Our technology

FASTinov patented methodology is based on an early detection of microbial cell lesions or metabolic changes, relying on a proprietary combination of particular fluorescent probes that target specific changes and make these identifiable through flow cytometry. The technology has been optimized such that no flow cytometry knowledge is needed to perform FASTinov AST. Advanced proprietary FASTinov computation then interprets the complex cytometry information and classifies bacterial cells in terms of their susceptibility phenotype in a growth independent manner.

Read More

Our Products

FASTinov AST kits are available and CE-marked for bloodstream infections by either Gram-Positive or Gram-Negative bacteria.

Each test uses one FASTinov AST kit and the bioFAST software to generate the report.

all-in-one-kit2

AST kit:

FASTEST semi-automated workflow: With a hands-on time of 5-10 minutes, the FASTinov AST delivers an antibiogram in less than 2 hours.

Learn More...
biofast-software2

bioFAST software:

A dedicated, proprietary software that processes the flow cytometry data and generates the AST report, providing Susceptible, Intermediate or Resistant...

Learn More...

Recent News

Norte2020
Portugal2020
União Europeia
Health Cluster Portugal